MGTX — MeiraGTx Holdings plc
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1735438 ·
Last close
$14.83
Market Cap
$1.42B
52W High
$15.35
52W Low
$8.89
ADV30
578,218
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 293,000 | 95,000 | -40,817,000 | -46,313,000 | 244,655,000 | 71,541,000 | 302,785,000 |
| Dec 2025 | 75,364,000 | 74,888,000 | 26,472,000 | 15,088,000 | 244,430,000 | 65,931,000 | 250,223,000 |
| Sep 2025 | 410,000 | 97,000 | -46,051,000 | -50,513,000 | 189,471,000 | 14,841,000 | 230,028,000 |
| Jun 2025 | 3,691,000 | 1,015,000 | -44,793,000 | -38,795,000 | 198,716,000 | 32,166,000 | 195,756,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$8,343,000
Investing CF
$-4,655,000
Financing CF
$446,000
CapEx
$-4,784,000
Dividends Paid
—
Buybacks
$-18,193,000
EPS Diluted TTM
$-2.18
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-862,536,000
Inventory
$0
Receivables
$17,959,000
ST Investments
—
EBIT TTM
$-108,531,000
Pretax Income TTM
$-120,533,000
Interest Exp TTM
$12,002,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$397,500,992
EBITDA
$196,131,008
Free Cash Flow
$56,421,000
Enterprise Value
$1,393,681,664
Total Cash
$143,166,000
Total Debt
$112,321,000
Shares Out
96,042,996
Trailing EPS
$0.90
Book Value
$2.29
ROE
72.2%
ROA
38.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 81,391,000 | -105,968,000 | -114,201,000 | 244,430,000 | 250,223,000 | — | -46,359,000 |
| Dec 2024 | 33,279,000 | -164,212,000 | -147,791,000 | 269,751,000 | 201,924,000 | — | -104,495,000 |
| Dec 2023 | 14,017,000 | -137,061,000 | -84,027,000 | 326,744,000 | 188,567,000 | — | -105,365,000 |
| Dec 2022 | 15,920,000 | -116,355,000 | -129,615,000 | 318,237,000 | 200,499,000 | — | -73,098,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.39
Max Pain — expiry 2026-10-16
max pain strike: $10.00 · spot: $14.83 · call oi: 1,043 · put oi: 54
Expected Move to 2026-10-16:
±$2.62
(17.67%) —
implied range
$12.21 –
$17.45
· ATM straddle on $15.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | $1.40B | $21.82 | — |
| NVAX | NOVAVAX INC | $1.46B | $8.86 | — |
| REPL | Replimune Group, Inc. | $1.39B | $14.71 | — |
| SLBT | SL Science Holding Ltd | $1.52B | $2.71 | — |
| INBX | Inhibrx Biosciences, Inc. | $1.54B | $104.94 | — |
News headlines (Yahoo Finance, 1h cache)
What Could MeiraGTx Holdings (MGTX) New Hires And Profit Swing Signal?
2026-08-14 23:12 · Yahoo
MeiraGTx Seen Nearing First Commercial Launches as Key Programs Advance, RBC Says
2026-08-14 16:02 · Yahoo
MeiraGTx Holdings PLC (MGTX) Q2 Earnings and Revenues Surpass Estimates
2026-08-13 13:25 · Yahoo
MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-08-06 20:30 · Yahoo
Wall Street Analysts See a 128.14% Upside in MeiraGTx (MGTX): Can the Stock Really Move This High?
2026-07-15 13:55 · Yahoo
What This MeiraGTx Insider Sale Might Mean With Two Drug Filings Near
2026-07-12 19:39 · Yahoo
MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)
2026-07-07 11:30 · Yahoo
Can MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint
2026-05-20 12:36 · Yahoo
Here's What Analysts Are Forecasting For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its First-Quarter Results
2026-05-17 13:55 · Yahoo
MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Lags Revenue Estimates
2026-05-14 13:10 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.